â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ“  **LAYER 5 â€” SYNTHESIS**
    Gemini synthesising 3 completed step(s)...
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
ğŸ”¬ **QUERY**    : Identify genes associated with Spinal Muscular Atrophy (SMA), find their disease relationships, and gather supporting experimental evidence.
ğŸ¤– **MODEL**    : gemini-2.5-pro
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

## ğŸ¯ Direct Answer
The gene `ATP7A` has a "Moderate" association with X-linked distal spinal muscular atrophy type 3, according to a 2023 ClinGen report. While this specific gene is linked to a subtype of SMA, knowledge graph analysis strongly implicates "regulation of RNA splicing" and "alternative nuclear mRNA splicing" as the core biological mechanisms to investigate for broader therapeutic development.

## ğŸ§¬ Gene & Biological Context
ClinGen's Charcot-Marie-Tooth Disease Gene Curation Expert Panel has classified the gene-disease relationship between **`ATP7A`** and **X-linked distal spinal muscular atrophy type 3 (MONDO:0010338)** as **Moderate**. This classification, updated in January 2023, indicates there is evidence supporting the association, but it does not yet meet the criteria for a "Strong" or "Definitive" link. The provided data did not identify genes for other forms of SMA, focusing solely on this specific X-linked variant.

## ğŸ“š Current Research Landscape
The current research landscape, based on the provided data, is focused on clinical guidelines and genetic testing rather than novel basic science. No recent preprints were identified on bioRxiv. Analysis of recent publications highlights themes such as establishing consensus for preimplantation genetic testing and updating international care recommendations to incorporate new disease-modifying treatments (DMTs). The primary author group identified is **"The Expert Consensus Group For Preimplantation Genetic Testing For Spinal Muscular Atrophy,"** underscoring a focus on standardizing clinical practice.

## ğŸ”¬ Knowledge Graph Connections
The Open Research Knowledge Graph (ORKG) provides critical mechanistic insight, identifying key concepts semantically linked to SMA:
-   regulation of RNA splicing
-   alternative nuclear mRNA splicing, via spliceosome

These connections reveal that the core molecular pathology of SMA is understood to be a defect in RNA processing. The semantic relationship highlights that the disease state is directly connected to the malfunction of the spliceosome. This suggests that a primary research direction should be the investigation of pathways that modulate RNA splicing. The low number of connections (3) indicates that while this core concept is captured, the broader network of genes, pathways, and experimental findings related to SMA is not yet deeply represented in the ORKG, signifying an opportunity for semantic data contribution.

## ğŸ‘¤ Key Researchers to Follow
The search identified authoring groups and publication titles rather than individual researchers. These entities are active in publishing clinical consensus and recommendations.

1.  **The Expert Consensus Group For Preimplantation Genetic Testing For Spinal Muscular Atrophy** â€” H-index: 1 | Citations: 2 | Institution: Not specified (Consensus Group)
2.  **The 2018 international care recommendations for spinal muscular atrophy (SMA) were published prior to the availability of disease-modifying treatments (DMTs)** â€” H-index: 0 | Citations: 0 | Institution: Not specified (Publication Title)

No individual authors from recent preprints were identified as being highly active in this specific data set.